查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1298024

感染控制市場、份額、規模、趨勢、行業分析報告：按類型、最終用途、按地區、細分市場預測，2023-2032 年

Infection Control Market Share, Size, Trends, Industry Analysis Report, By Type; End-use; By Region; Segment Forecast, 2023 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，到2032年，全球感染控制市場預計將達到4008.1億美元。 該研究報告提供了對當前市場動態的詳細見解，並對未來市場增長進行了分析。

需要嚴格感染控制措施的外科手術的增加是市場的主要驅動力。 據信，感染控制所提供的良好治療效果是其高適口性的原因。 由於醫院和診所、製藥和醫療器械行業對滅菌和消毒的需求增加，COVID-19 大流行對市場增長產生了積極影響。

根據世界衛生組織關於預防醫院感染的實用建議，因手術感染而導致的額外住院時間估計約為8天。 住院時間的延長預計將導致住院費用大幅增加，使得臨床上實施感染預防措施變得更加緊迫。 對於醫院和醫療保健支付者來說，較長的住院時間預計會降低成本效益，因為他們使用過多的資源來治療獲得性感染。

全球感染控制市場競爭激烈且較為分散。 市場進入者正專注於新產品發布、產品開發和全球增長，以提高其市場份額。 該市場的主要參與者包括 Fortive（高級滅菌產品）、3M 公司、Getinge AB、Steris PLC 和 Cantel Medical Corporation。

肺炎、血流感染、尿路感染、手術部位感染、MRSA是醫院感染的主要原因。 其他重要的醫院獲得性感染 (HAIs) 包括導管相關血流、導管相關尿路感染和呼吸機相關肺炎。 HAI 是全球範圍內阻礙患者康復並顯著增加死亡率的主要問題之一。

感染控制市場報告要點

醫院將在 2022 年佔據最大的收入份額，並預計在整個預測期內以最快的複合年增長率 (CAGR) 增長。 傳染病比例高的主要原因是醫院場所感染呼吸道和血源性病原體的風險較高。

2022 年，北美地區的行業份額處於領先地位。 該細分市場市場份額的增加可能是主要市場進入者之間持續建立戰略聯盟以增強其產品供應和感染控制能力的結果。 北美的主導市場份額也是由於現有企業為在該地區建立自己的地位而做出的更大努力。

內容

第一章簡介

第 2 章執行摘要

第三章研究方法

第 4 章全球感染控制市場洞察

  • 感染控制市場 - 行業概況
  • 感染控制市場動態
    • 驅動因素和機遇
      • 需要徹底感染控制的外科手術數量增加
      • 政府機構越來越多地參與
    • 制約因素和問題
      • 成本高
  • 杵分析
  • 感染控制行業趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第 5 章全球感染控制市場（按類型）

  • 主要發現
  • 簡介
  • 設備
  • 服務
  • 消耗品
  • 其他

第 6 章全球感染控制市場（按最終用途）

  • 主要發現
  • 簡介
  • 醫院
  • 醫療器械公司
  • 臨床實驗室
  • 醫藥研究院
  • 其他

第 7 章全球感染控制市場：按地區

  • 主要發現
  • 簡介
    • 2019-2032 年按地區劃分的感染控制市場評估
  • 感染控制市場 - 北美
    • 北美：感染控制市場，按最終用途，2019-2032 年
    • 北美：感染控制市場（按類型），2019-2032 年
    • 感染控制市場 - 美國
    • 感染控制市場 - 加拿大
  • 感染控制市場 - 歐洲
    • 歐洲：感染控制市場（按最終用途），2019-2032 年
    • 歐洲：感染控制市場（按類型），2019-2032 年
    • 感染控制市場 - 英國
    • 感染控制市場 - 法國
    • 感染控制市場 - 德國
    • 感染控制市場 - 意大利
    • 感染控制市場 - 西班牙
    • 感染控制市場 - 荷蘭
    • 感染控制市場 - 俄羅斯
  • 感染控制市場 - 亞太地區
    • 亞太地區：按最終用途劃分的傳染病控制市場，2019-2032 年
    • 亞太地區：感染控制市場（按類型），2019-2032 年
    • 感染控制市場 - 中國
    • 感染控制市場 - 印度
    • 感染控制市場 - 馬來西亞
    • 感染控制市場 - 日本
    • 感染控制市場 - 印度尼西亞
    • 感染控制市場 - 韓國
  • 感染控制市場 - 中東和非洲
    • 中東和非洲：按最終用途劃分的傳染病控制市場，2019-2032 年
    • 中東和非洲：感染控制市場（按類型），2019-2032 年
    • 感染控制市場 - 沙特阿拉伯
    • 感染控制市場 - 阿拉伯聯合酋長國
    • 感染控制市場 - 以色列
    • 感染控制市場 - 南非
  • 感染控制市場 - 拉丁美洲
    • 拉丁美洲：傳染病控制市場，按最終用途，2019-2032 年
    • 拉丁美洲：感染控制市場（按類型），2019-2032 年
    • 感染控制市場 - 墨西哥
    • 感染控制市場 - 巴西
    • 感染控制市場 - 阿根廷

第 8 章競爭格局

  • 擴張和收購分析
    • 擴展名
    • 收購
  • 夥伴關係/協作/協議/披露

第 9 章公司簡介

  • 3M Company
  • Belimed AG
  • Halyard Health
  • Getinge Group
  • Matachana Group
Product Code: PM3241

The global infection control market size is expected to reach USD 400.81 billion by 2032, according to a new study by Polaris Market Research. The report "Infection Control Market Share, Size, Trends, Industry Analysis Report, By Type (Equipment, Services, Consumables, Others); End-use; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rise in surgical procedures that require rigorous infection control is the main factor driving the market. The positive therapeutic outcomes produced using infection control are regarded to be the cause of the high preference. The COVID-19 pandemic has positively impacted market growth due to the rise in demand for sterilization and disinfection in hospitals and clinics, pharmaceutical and medical device sectors.

According to the WHO's practical advice on the prevention of HAI, the extra amount of time spent in the hospital due to surgical infections was estimated to be around 8 days. These prolonged stays are anticipated to result in a large increase in hospital costs, which heightens the clinical urgency for implementing infection prevention measures. It is anticipated that prolonged hospital stays are not cost-effective for hospitals and healthcare payers as a result of the excessive use of resources to treat the acquired infection.

The market for infection control on a global scale is competitive and only somewhat fragmented. Industry participants are focusing on new product releases, product developments, and global growth in order to improve their market share. Some of the key players in the market include Fortive (Advanced Sterilization Products), 3M Company, Getinge AB, Steris PLC, and Cantel Medical Corporation.

Diseases include pneumonia, infections of the bloodstream, urinary tract, surgical site, and MRSA are the main causes of hospital-acquired infections. Other prominent hospital-acquired infections (HAI) include catheter-related bloodstreams, catheter-associated urinary tract infections, and pneumonia related to ventilators. HAI is one of the major problems that hinders patient recovery and significantly affects death rates globally.

Infection Control Market Report Highlights

Hospitals held the biggest revenue share in 2022 and are projected to grow at the fastest rate (CAGR) throughout the course of the forecast period. The significant portion of infections is primarily due to the high risk of contracting diseases on hospital property through respiratory or bloodborne pathogen transmission.

North America led the industry share in 2022. The increased market share that this sector has managed to capture is regarded to be a result of a consistent number of strategic partnerships taken up by major market participants to increase their product offering and infection control capabilities. The greater efforts made by existing companies to establish themselves throughout this region are also to blame for North America's dominant market share.

3M Corporation, Belimed AG, Halyard Health, Getinge Group, Matachana Group, and others are some of the leading companies competing in the international market.

Polaris Market Research has segmented the Infection Control Market report based on type, end-use, and region:

Infection Control Market, Type (Revenue - USD Billion, 2019 - 2032)

  • Equipment
  • Services
  • Consumables
  • Others

Infection Control Market, End Use (Revenue - USD Billion, 2019 - 2032)

  • Hospital
  • Medical Device Company
  • Pharmaceutical Laboratories

Infection Control Market, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Infection Control Market Insights

  • 4.1. Infection Control Market - Industry Snapshot
  • 4.2. Infection Control Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increase of surgical procedures that demand intensive infection control
      • 4.2.1.2. Rising involvement of government agencies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Infection Control Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Infection Control Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Infection Control, by Type, 2019-2032 (USD Billion)
  • 5.3. Equipment
    • 5.3.1. Global Infection Control Market, by Equipment, by Region, 2019-2032 (USD Billion)
  • 5.4. Services
    • 5.4.1. Global Infection Control Market, by Services, by Region, 2019-2032 (USD Billion)
  • 5.5. Consumables
    • 5.5.1. Global Infection Control Market, by Consumables, by Region, 2019-2032 (USD Billion)
  • 5.6. Others
    • 5.6.1. Global Infection Control Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Infection Control Market, by End-Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • 6.3. Hospitals
    • 6.3.1. Global Infection Control Market, by Hospitals, by Region, 2019-2032 (USD Billion)
  • 6.4. Medical Device Companies
    • 6.4.1. Global Infection Control Market, by Medical Device Companies, by Region, 2019-2032 (USD Billion)
  • 6.5. Clinical Laboratories
    • 6.5.1. Global Infection Control Market, by Clinical Laboratories, by Region, 2019-2032 (USD Billion)
  • 6.6. Pharmaceutical Laboratories
    • 6.6.1. Global Infection Control Market, by Pharmaceutical Laboratories, by Region, 2019-2032 (USD Billion)
  • 6.7. Others
    • 6.7.1. Global Infection Control Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Infection Control Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Infection Control Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 7.3. Infection Control Market - North America
    • 7.3.1. North America: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
    • 7.3.2. North America: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.3.3. Infection Control Market - U.S.
      • 7.3.3.1. U.S.: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.3.3.2. U.S.: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.3.4. Infection Control Market - Canada
      • 7.3.4.1. Canada: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.3.4.2. Canada: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • 7.4. Infection Control Market - Europe
    • 7.4.1. Europe: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
    • 7.4.2. Europe: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.4.3. Infection Control Market - UK
      • 7.4.3.1. UK: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.3.2. UK: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.4.4. Infection Control Market - France
      • 7.4.4.1. France: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.4.2. France: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.4.5. Infection Control Market - Germany
      • 7.4.5.1. Germany: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.5.2. Germany: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.4.6. Infection Control Market - Italy
      • 7.4.6.1. Italy: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.6.2. Italy: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.4.7. Infection Control Market - Spain
      • 7.4.7.1. Spain: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.7.2. Spain: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.4.8. Infection Control Market - Netherlands
      • 7.4.8.1. Netherlands: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.8.2. Netherlands: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.4.9. Infection Control Market - Russia
      • 7.4.9.1. Russia: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.4.9.2. Russia: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • 7.5. Infection Control Market - Asia Pacific
    • 7.5.1. Asia Pacific: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
    • 7.5.2. Asia Pacific: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.5.3. Infection Control Market - China
      • 7.5.3.1. China: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.3.2. China: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.5.4. Infection Control Market - India
      • 7.5.4.1. India: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.4.2. India: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.5.5. Infection Control Market - Malaysia
      • 7.5.5.1. Malaysia: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.5.2. Malaysia: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.5.6. Infection Control Market - Japan
      • 7.5.6.1. Japan: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.6.2. Japan: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.5.7. Infection Control Market - Indonesia
      • 7.5.7.1. Indonesia: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.7.2. Indonesia: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.5.8. Infection Control Market - South Korea
      • 7.5.8.1. South Korea: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.5.8.2. South Korea: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • 7.6. Infection Control Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
    • 7.6.2. Middle East & Africa: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.6.3. Infection Control Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.6.4. Infection Control Market - UAE
      • 7.6.4.1. UAE: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.6.4.2. UAE: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.6.5. Infection Control Market - Israel
      • 7.6.5.1. Israel: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.6.5.2. Israel: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.6.6. Infection Control Market - South Africa
      • 7.6.6.1. South Africa: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.6.6.2. South Africa: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • 7.7. Infection Control Market - Latin America
    • 7.7.1. Latin America: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
    • 7.7.2. Latin America: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.7.3. Infection Control Market - Mexico
      • 7.7.3.1. Mexico: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.7.3.2. Mexico: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.7.4. Infection Control Market - Brazil
      • 7.7.4.1. Brazil: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.7.4.2. Brazil: Infection Control Market, by Type, 2019-2032 (USD Billion)
    • 7.7.5. Infection Control Market - Argentina
      • 7.7.5.1. Argentina: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
      • 7.7.5.2. Argentina: Infection Control Market, by Type, 2019-2032 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. 3M Company
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Belimed AG
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Halyard Health
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Getinge Group
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Matachana Group
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development

List of Tables

  • Table 1 Global Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 2 Global Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 3 Infection Control Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 4 North America: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 5 North America: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 6 U.S.: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 7 U.S.: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 8 Canada: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 9 Canada: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 10 Europe: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 11 Europe: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 12 UK: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 13 UK: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 14 France: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 15 France: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 16 Germany: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 17 Germany: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 18 Italy: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 19 Italy: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 20 Spain: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 21 Spain: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 22 Netherlands: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 23 Netherlands: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 24 Russia: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 25 Russia: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 26 Asia Pacific: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 27 Asia Pacific: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 28 China: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 29 China: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 30 India: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 31 India: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 32 Malaysia: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 33 Malaysia: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 34 Japan: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 35 Japan: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 36 Indonesia: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 37 Indonesia: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 38 South Korea: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 39 South Korea: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 40 Middle East & Africa: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 41 Middle East & Africa: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 42 Saudi Arabia: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 43 Saudi Arabia: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 44 UAE: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 45 UAE: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 46 Israel: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 47 Israel: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 48 South Africa: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 49 South Africa: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 50 Latin America: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 51 Latin America: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 52 Mexico: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 53 Mexico: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 54 Brazil: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 55 Brazil: Infection Control Market, by Type, 2019-2032 (USD Billion)
  • Table 56 Argentina: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
  • Table 57 Argentina: Infection Control Market, by Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1 Global Infection Control Market, 2019-2032 (USD Billion)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by End-Use
  • Figure 7 Global Infection Control Market, by End-Use, 2022 & 2032 (USD Billion)
  • Figure 8 Market by Type
  • Figure 9 Global Infection Control Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 10 Infection Control Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 11 Strategic Analysis - Infection Control Market